Invasive Fungal Infections After Liver Transplantation: A Retrospective Matched Controlled Risk Analysis

06 August 2021: Original Paper

Halil-Ibrahim Karadag ^1ACDEF , Oya Andacoglu ^2CDEF , Marios Papadakis ^3BCEF , Andreas Paul ^1ACD , Arzu Oezcelik ^1ACDE* , Eugen Malamutmann ^1AD

DOI: 10.12659/AOT.930117

Ann Transplant 2021; 26:e930117

Table 1 Comparison of the preoperative recipient data.

	AGn=14	CGn=19	Controln=99	p-value
Mean age (SD)	52.5 (12.9)	48 (10.8)	49.9 (12.3)	0.177
Sex (Male/Female)	9/5	10/9	62/37	0.913
BMI (IQR)	23.8 (20.5–29.8)	26.9 (22.9–31.1)	25.2 (22.3–29.4)	0.443
Abdominal surgery (n)	8	9	43	0.586
Portal vein thrombosis (%)	3	0	9	0.108
MELD-score (IQR)	26 (15–34)	18 (13–25)	19 (14–30)	0.456
AG – Aspergillus group; CG – Candida group; BMI – body mass index; MELD – Model for End-Stage Liver Disease; IQR – inter-quartile range; SD – standard deviation.